Dudley & Shanley Inc. Has $29.60 Million Stock Holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Dudley & Shanley Inc. trimmed its position in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 0.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 461,381 shares of the company’s stock after selling 240 shares during the period. Ryan Specialty accounts for 4.6% of Dudley & Shanley Inc.’s portfolio, making the stock its 7th largest holding. Dudley & Shanley Inc.’s holdings in Ryan Specialty were worth $29,602,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of RYAN. GAMMA Investing LLC lifted its position in shares of Ryan Specialty by 38.1% in the fourth quarter. GAMMA Investing LLC now owns 1,725 shares of the company’s stock valued at $111,000 after acquiring an additional 476 shares in the last quarter. JPMorgan Chase & Co. raised its position in shares of Ryan Specialty by 107.5% during the third quarter. JPMorgan Chase & Co. now owns 459,464 shares of the company’s stock valued at $30,504,000 after buying an additional 238,064 shares during the last quarter. Principal Financial Group Inc. lifted its holdings in shares of Ryan Specialty by 148.9% in the third quarter. Principal Financial Group Inc. now owns 851,704 shares of the company’s stock worth $56,545,000 after buying an additional 509,548 shares in the last quarter. Tidal Investments LLC boosted its position in shares of Ryan Specialty by 30.4% during the third quarter. Tidal Investments LLC now owns 12,255 shares of the company’s stock worth $814,000 after acquiring an additional 2,858 shares during the last quarter. Finally, Wilmington Savings Fund Society FSB purchased a new position in Ryan Specialty during the third quarter valued at $193,000. Institutional investors own 84.82% of the company’s stock.

Insider Transactions at Ryan Specialty

In related news, Director Nicholas Dominic Cortezi sold 35,000 shares of the business’s stock in a transaction that occurred on Wednesday, December 18th. The shares were sold at an average price of $65.17, for a total value of $2,280,950.00. Following the completion of the transaction, the director now owns 50,400 shares of the company’s stock, valued at $3,284,568. The trade was a 40.98 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Mark Stephen Katz sold 14,790 shares of Ryan Specialty stock in a transaction on Friday, November 8th. The shares were sold at an average price of $71.39, for a total value of $1,055,858.10. Following the completion of the transaction, the executive vice president now owns 12,386 shares in the company, valued at $884,236.54. This represents a 54.42 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 126,936 shares of company stock valued at $8,536,282. 11.10% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several analysts have commented on the stock. Barclays boosted their price target on shares of Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a research note on Thursday, November 21st. Bank of America increased their price target on Ryan Specialty from $75.00 to $84.00 and gave the company a “buy” rating in a research note on Thursday, October 10th. BMO Capital Markets raised Ryan Specialty from a “market perform” rating to an “outperform” rating and upped their price objective for the stock from $65.00 to $75.00 in a report on Tuesday, September 24th. Morgan Stanley assumed coverage on shares of Ryan Specialty in a research report on Thursday, December 5th. They issued an “overweight” rating and a $90.00 price target on the stock. Finally, Wells Fargo & Company lifted their price objective on shares of Ryan Specialty from $63.00 to $70.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 10th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and six have given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $73.50.

Ryan Specialty Trading Up 0.8 %

Shares of NYSE:RYAN traded up $0.51 on Friday, hitting $63.14. 193,154 shares of the company’s stock were exchanged, compared to its average volume of 469,664. The business’s 50 day simple moving average is $69.11 and its two-hundred day simple moving average is $65.36. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. The stock has a market capitalization of $16.53 billion, a price-to-earnings ratio of 82.00, a price-to-earnings-growth ratio of 1.52 and a beta of 0.67. Ryan Specialty Holdings, Inc. has a 12 month low of $41.65 and a 12 month high of $75.97.

Ryan Specialty (NYSE:RYAN) last issued its earnings results on Wednesday, October 30th. The company reported $0.41 EPS for the quarter, hitting analysts’ consensus estimates of $0.41. Ryan Specialty had a net margin of 10.31% and a return on equity of 47.90%. The business had revenue of $604.69 million for the quarter, compared to the consensus estimate of $602.04 million. During the same period in the prior year, the firm earned $0.32 EPS. The company’s revenue for the quarter was up 20.5% compared to the same quarter last year. Analysts anticipate that Ryan Specialty Holdings, Inc. will post 1.82 EPS for the current fiscal year.

Ryan Specialty Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Shareholders of record on Tuesday, November 12th were issued a $0.11 dividend. This represents a $0.44 annualized dividend and a dividend yield of 0.70%. The ex-dividend date of this dividend was Tuesday, November 12th. Ryan Specialty’s dividend payout ratio is 57.14%.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.